Lisinopril Tablets

Free

Lisinopril Tablets IP 2.5 mg
Each Film coated tablet contains:
Lisinopril IP 2.5 mg

Lisinopril Tablets IP 5 mg
Each Film coated tablet contains:
Lisinopril IP 5 mg

Lowpril
Lisinopril Tablet BP
Each Film Coated Tablet Contains:
Lisinopril Dihydrate BP
eq. To Lisinopril Anhydrous 20 mg

Usage: – Treat high blood pressure and heart failure

Category: – Anti Hypertensive / Cardiac Drugs

Enquire on WhatsApp Request a Callback!

SKU: Lisinopril Tablets Category: Tablets Tags: ACE Inhibitor Exporter, ACE阻害薬, Antihypertenseur Afrique, B2B Pharma Marketplace, Cardiovascular Exporter Southeast Asia, CAS 83915-83-7, Comprimés de Lisinopril, comprimidos de lisinopril, Contract Manufacturing Antihypertensives, Diabetic Nephropathy Treatment, Distributors India, Exporters, Generic Supplier, Global Pharmaceutical Suppliers Vietnam Nigeria Philippines UAE, Government Tender Pharma Supplier, Healthy Inc Cardiovascular, Heart Failure Drug India, Hospital Bulk Supply Cardiology, HS Code 30049069, Hypertension Medicine Supplier, Lisinopril 20mg Tablets, Lisinopril Manufacturer India., Lisinopril Manufacturer Mumbai, Lisinopril Supplier Africa, Lisinopril Tablets, Lisinopril Tablets 10mg, Medicine Export to Philippines, Medicine Export to Vietnam, Ministry of Health Hypertension Tender, Pharmaceutical Drop Shipper Mumbai, Prinivil Generic India, Renal Protection Drug, suppliers India, Tabletas de Lisinopril, Third Party Manufacturing Pharma, Tratamiento de la Hipertensión, WHO GMP Certified Lisinopril Unit, who gmp certified manufacturer, Wholesalers India, Zestril Generic, Лизиноприл таблетки, Средство от давления, Таблетки Лизиноприл., أقراص ليسينوبريل, دواء لعلاج ضغط الدم المرتفع, علاج فشل القلب, قرص ليزينوبريل . ملجم ملجم ملجم, लिसिनोप्रिल गोलियाँ .एमजीएमजीएमजी, リシノプリル錠, リシノプリル錠。, 心力衰竭药物, 片賴諾普利錠 . 毫克毫克毫克, 糖尿病肾病治疗, 赖诺普利片, 降压药

Description

Description

Lisinopril Tablets (5 mg / 10 mg / 20 mg)

Healthy Inc is a premier global supplier of high-precision cardiovascular therapies. We provide premium Lisinopril Tablets, manufactured in WHO–GMP certified specialized solid dosage units. As a frontline ACE inhibitor for hypertension and congestive heart failure, this product is a vital export for cardiology clinics, geriatric care networks, and Ministry of Health (MOH) tenders in Southeast Asia, Africa, and the Middle East.

Product Overview

Lisinopril is a potent, long-acting, non-sulfhydryl Angiotensin-Converting Enzyme (ACE) inhibitor. Unlike many other ACE inhibitors, Lisinopril is not a prodrug; it is active upon ingestion and is not metabolized by the liver, making it an ideal choice for patients with hepatic impairment.

The “Vascular Protector” Specialist:

Mechanism of Action: Lisinopril inhibits the ACE enzyme, preventing the conversion of Angiotensin I to the potent vasoconstrictor Angiotensin II. This results in decreased vasopressor activity, reduced aldosterone secretion, and a significant reduction in systemic vascular resistance (afterload).
Cardioprotective Benefits: It is clinically indicated for use within 24 hours of an acute myocardial infarction to improve survival and prevent the development of left ventricular dysfunction and heart failure.
Renal Preservation: In patients with Type 2 Diabetes, Lisinopril provides significant nephroprotection by reducing albuminuria and slowing the progression of diabetic nephropathy.

Technical & Manufacturing Specifications

Formulated for absolute dose uniformity and long-term chemical stability.

Technical Metric	Specification Standard
Active Ingredient	Lisinopril Dihydrate BP / USP / IP
Dosage Form	Immediate Release Tablets
Available Strengths	2.5 mg, 5 mg, 10 mg, 20 mg, 40 mg
HS Code	3004.90.69 (Antihypertensives) / 2933.39.19
Packaging	Alu-Alu or PVC-PVDC Blister

Manufacturing Authority

Marketed and Distributed by Healthy Inc from ISO 9001:2015 certified units.

Liver-Bypass Kinetics: Because Lisinopril is not metabolized by the liver, our formulation focuses on consistent dissolution profiles to ensure predictable renal clearance and plasma concentration, regardless of the patient’s hepatic status.
HAPI Containment: Manufactured in controlled environments to prevent cross-contamination, ensuring that our cardiovascular range meets the stringent purity requirements for chronic, life-long therapy.
Stability Validation: Validated for Zone IVb (40°C / 75% RH). Our tablets maintain their structural integrity and chemical potency for 36 months in tropical climates, a key requirement for our African and Southeast Asian distributors.

Therapeutic Indications & Clinical Symptoms

Hypertension: Management of essential and renovascular hypertension as monotherapy or in combination with diuretics.
Heart Failure: Adjunctive therapy with diuretics and digitalis to manage symptomatic congestive heart failure.
Acute Myocardial Infarction: Early treatment to prevent hemodynamic instability and improve long-term outcomes.
Diabetic Nephropathy: Reduction of urinary albumin excretion in hypertensive microalbuminuric patients.

Dosage & Administration

Hypertension: Initial dose of 10 mg once daily, titrated based on clinical response (usual range 20–40 mg).
Renal Adjustment: Dosage must be adjusted in patients with a Creatinine Clearance < 30 mL/min.
Safety Note: Monitor for hyperkalemia and the “ACE-cough.” Contraindicated in pregnancy (Risk of fetal toxicity) and in patients with a history of angioedema.

Global Export & Contract Manufacturing Services

Healthy Inc is a verified Pharmaceutical Exporter in Mumbai, catering to Cardiovascular Specialty Centers and Ministry of Health Tenders. We offer Third Party Manufacturing for Lisinopril with full CTD Dossier and COPP support. Our logistics network ensures secure transit to Vietnam, Nigeria, Philippines, and the UAE, providing WHO-GMP quality at competitive B2B prices.